PDF) Strategies in clozapine-resistant schizophrenia: A literature review
Treatment-Resistant Schizophrenia Guideline | Psychiatrist.com
Medical | PDF | American Medical Association | Pharmacology
Frontiers | N-acetyl Cysteine Administration Is Associated With Increased Cerebral Glucose Metabolism in Patients With Multiple Sclerosis: An Exploratory Study
Frontiers | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Vicks Drug of Choice List | PDF | Enzyme Inhibitor | Nonsteroidal Anti Inflammatory Drug
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia | SpringerLink
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions | Journal of Medicinal Chemistry
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia | SpringerLink
PDF) N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double blind randomised placebo controlled trial targeting negative symptoms
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Annual Report 2008 - Istituto di Ricerche Farmacologiche Mario Negri
Assessing Psychiatric Adverse Effects during Clinical Drug Development | SpringerLink
PDF) Receptor Mechanisms in the treatment of Schizophrenia
Geneesmiddelengebruik in de belgische rusthuizen en rust ... - KCE
PDF) N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double blind randomised placebo controlled trial targeting negative symptoms
Case study: treatment-resistant schizophrenia - The Pharmaceutical Journal
Effect of N-acetylcysteine on clozapine-induced sialorrhea in schizophrenic patients: a case series
PDF) N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double blind randomised placebo controlled trial targeting negative symptoms
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review - ScienceDirect
Criteria indicating treatment-resistant schizophrenia, and proxy... | Download Scientific Diagram
Frontiers | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration | Journal of Medicinal Chemistry
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy | SpringerLink
RETRACTED ARTICLE: Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials | SpringerLink
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study - The Lancet Psychiatry
